Medivizor

Title of notification

Here comes the notification
X
 
icon
prostate cancer | Medivizor | source: Medivizor | Added Jul 26, 2021

Cancer Patient Resources: Free Air Travel

Cost Medical care for cancer is costly. In addition, there is the financial burden that patients and families face in getting to and from the best care--which may be located at medical centers far from home. The situation can seem overwhelming. Corporate Angel Network Into this dilemma, little known resources
icon
icon
prostate cancer | Research | Treatment | 10 pages | source: International journal of radiation oncology, biology, physics | Added Jul 24, 2021

Evaluating hypofractionated radiotherapy after prostate surgery in patients with prostate cancer.

This study investigated the outcomes of hypofractionated intensity-modulated radiation therapy (H-IMRT) to the prostate bed in patients with localized prostate cancer after prostate surgery. The data showed that H-IMRT after prostate surgery was safe and well-tolerated in these patients.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: Journal of Urology | Added Jul 20, 2021

Comparing darolutamide with apalutamide and enzalutamide for treating non-metastatic castration-resistant prostate cancer.

The study compared the effectiveness and safety outcomes of darolutamide (Nubeqa) with apalutamide (Erleada) and enzalutamide (Xtandi) in treating non-metastatic castration-resistant prostate cancer (CRPC). The data showed that darolutamide was safer and had similar effectiveness compared to apalutamide and enzalutamide.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added Jul 17, 2021

Comparing docetaxel to abiraterone in patients with metastatic castration-sensitive prostate cancer

This study compared the effectiveness of docetaxel (DOC; Taxotere) to abiraterone (ABI; Zytiga) and assessed possible predictive markers of progression-free survival (PFS) in patients with metastatic castration-sensitive prostate cancer (mCSPC). The authors concluded that under real-world conditions, ABI was associated with better PFS in these patients.

icon
prostate cancer | Research | 10 pages | source: Cancer | Added Jul 15, 2021

Does androgen-deprivation therapy increase risk of mortality from heart attack or stroke?

This study examined the risk of heart-related mortality in patients undergoing androgen-deprivation therapy (ADT) for prostate cancer. It found that patients treated with radiation therapy and ADT did not have an increased risk of heart-related mortality.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: PLOS ONE | Added Jul 12, 2021

Evaluating the association between the lowest PSA value after prostate surgery and the occurrence of biochemical recurrence in patients with localized prostate cancer

This study investigated the association between the lowest PSA value after radical prostatectomy (RP; surgery to remove the prostate) and the occurrence of biochemical recurrence (BCR) in patients with localized prostate cancer (PCa). The study found that a higher PSA value after RP and a shorter time to reach this value could predict the risk of BCR in these patients.

icon
prostate cancer | Medivizor | source: Medivizor | Added Jul 10, 2021

What Should You Ask Your Doctor About Your Cancer Diagnosis?

Or Patient-Centered Cancer Care:  IOM’s recommendations Last week, we looked at the recent Institute of Medicine’s report and wrote the post about "How the US Got Its Cancer Care Crisis". This week we get more practical. With specific recommendations you can use! The general recommendations include: (1) becoming engaged patients. (2) ensuring
icon
prostate cancer | Medivizor | source: Medivizor | Added Jul 08, 2021

On Being a Cancer Survivor: Patient Experience of Peripheral Neuropathy

Being Informed For Vilma Aleida, neuropathy was a surprise. "Neuropathy appeared in 2011 during my 7th chemo....That 7th chemo was the infusion of two treatments (taxotere and trastuzumab). The result send me to the ER, the pain was only relieved with morphine. After that, I have been living with neuropathy
icon
icon
prostate cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added Jul 01, 2021

Evaluating the effectiveness of salvage radiotherapy for recurrence after prostate surgery in patients with localized prostate cancer.

This study evaluated the effectiveness of salvage radiotherapy (RT) in patients with recurrence of prostate cancer (PCa) after prostate surgery. The study found that salvage RT was effective in the management of PCa recurrence with manageable side effects.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: Journal of clinical oncology | Added Jun 29, 2021

Evaluating the long-term outcomes of apalutamide plus androgen deprivation therapy in metastatic castration-sensitive prostate cancer

This study reported the long-term effectiveness and safety outcomes of apalutamide (Erleada) in combination with androgen deprivation therapy (ADT) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC). The data showed that this combination improved survival, delayed castration resistance, and maintained the quality of life in these patients.

View

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?